Research and Practice in Thrombosis and Haemostasis

Title Publication Date Language Citations
Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis2020/10/01English334
Fibrinogen and fibrin: An illustrated review2019/04/01English141
Integrating platelet and coagulation activation in fibrin clot formation2018/07/01English117
The coagulation system in host defense2018/07/01English113
Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis2017/07/01English103
Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases2017/10/01English86
The dual role of platelet‐innate immune cell interactions in thrombo‐inflammation2020/01/01English85
Safety and effectiveness of apixaban compared to warfarin in dialysis patients2018/04/01English75
A proposal for staging COVID‐19 coagulopathy2020/07/01English72
Venous thromboembolism in critically Ill patients with COVID‐19: Results of a screening study for deep vein thrombosis2020/07/01English70
A review of commercially available thrombin generation assays2018/01/01English69
Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine2019/01/01English65
Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study2018/10/01English64
Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality2021/01/01English61
Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials2020/05/01English60
Polyphosphate in thrombosis, hemostasis, and inflammation2019/01/01English57
Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)2021/07/01English55
Using heparin molecules to manage COVID‐20192020/05/01English53
Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 20172019/10/01English52
Increased risk of thrombotic events in cold agglutinin disease: A 10‐year retrospective analysis2020/05/01English52
Circulating endothelial cells as biomarker for cardiovascular diseases2019/01/01English51
Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions2019/07/01English50
Sexism in the management of bleeding disorders2021/01/01English50
Current and future burden of venous thrombosis: Not simply predictable2018/04/01English49
Measurement of tissue factor activity in extracellular vesicles from human plasma samples2019/01/01English49
Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability2019/10/01English47
Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome2020/07/01English47
Tranexamic acid evidence and controversies: An illustrated review2021/07/01English46
BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics2019/04/01English44
What’s new in VTE risk and prevention in orthopedic surgery2020/03/01English44